Department of Endocrinology, Shandong University, Qilu Hospital, Jinan, Shandong, People's Republic of China.
Mol Med. 2012 Jul 18;18(1):816-24. doi: 10.2119/molmed.2011.00458.
Basal and adaptive β-cell regeneration capacity declines with old age, but the underlying molecular mechanisms remain incompletely understood. Poly (adenosine diphosphate [ADP]-ribose) polymerase 1 (PARP-1) is considered a multifunctional enzyme and transcription factor that regulates pancreatic β-cell death, regeneration and insulin secretion. We analyzed the capacity of β-cell regeneration in 2-month-old (young) and 12-month-old (old) wild-type (WT) and PARP-1⁻/⁻ mice before and after low-dose streptozotocin (STZ), a stimulus of β-cell regeneration and the underlying mechanism. Before STZ administration, young WT and PARP-1⁻/⁻ mice showed similar β-cell proliferation. By contrast, old WT but not old PARP-1⁻/⁻ mice showed severely restricted β-cell proliferation. In further assessment of the adaptive β-cell regeneration capacity with age, we observed that with a single low dose of STZ, young WT and PARP-1⁻/⁻ mice showed a similar increase in β-cell proliferation, with few changes in old WT mice. Surprisingly, adaptive β-cell proliferation capacity was significantly higher in old PARP-1⁻/⁻ mice than old WT mice after STZ administration. The ability of β-cell mass to expand was associated with increased levels of the regenerating (Reg) genes RegI and RegII but not RegIV. Therefore, PARP-1 is a key regulator in β-cell regeneration with advancing age in mice.
基础和适应性β细胞再生能力随着年龄的增长而下降,但潜在的分子机制仍不完全清楚。多聚(二磷酸腺苷核糖)聚合酶 1(PARP-1)被认为是一种多功能酶和转录因子,可调节胰腺β细胞的死亡、再生和胰岛素分泌。我们分析了低剂量链脲佐菌素(STZ)刺激β细胞再生前后 2 月龄(年轻)和 12 月龄(年老)野生型(WT)和 PARP-1⁻/⁻小鼠的β细胞再生能力及其潜在机制。在 STZ 给药前,年轻的 WT 和 PARP-1⁻/⁻小鼠表现出相似的β细胞增殖。相比之下,年老的 WT 小鼠但不是年老的 PARP-1⁻/⁻小鼠表现出严重限制的β细胞增殖。在进一步评估年龄对适应性β细胞再生能力的影响时,我们观察到,单次低剂量 STZ 给药后,年轻的 WT 和 PARP-1⁻/⁻小鼠的β细胞增殖相似,而年老的 WT 小鼠的变化很少。令人惊讶的是,STZ 给药后,年老的 PARP-1⁻/⁻小鼠的适应性β细胞增殖能力明显高于年老的 WT 小鼠。β细胞质量扩张的能力与再生(Reg)基因 RegI 和 RegII 的水平增加有关,但与 RegIV 无关。因此,PARP-1 是小鼠β细胞再生随年龄增长的关键调节因子。